In chronic DSS-induced colitis, both decreased expression of pro-inflammatory cytokines (TNF-α, NO, and IL-1β) and increased anti-inflammatory mediators (IL-10) in the colonic mucosa contributed to attenuate inflammation after Resveratrol treatment [29]. This evidence concerns the gene IL1B and colitis.